[PDF] Top 20 Understanding chronic myeloid leukaemia (CML)

... It can be hard to know the best way to talk to your children and explain CML without frightening them too much. Although many people live a normal life with CML, the words leukaemia and cancer can be very scary. ... See full document

... males, leukaemia is the most common cause of cancer-related death in individuals younger than 40 years of age whereas in female children and adolescents, leukaemia is the most common cause of cancer-related ... See full document

... The first recognition of a disease entity consistent with what we now call ‘Chronic Myeloid Leukaemia (CML)’ took place in 1845 by John Hughes Bennett (Edinburgh) [1]. This was accompanied by a ... See full document

... at the 5’ end, most frequently between exon 1a and 1b, although studies have shown breakpoints occurring upstream and downstream of exon 1b and exon 1a respectively (Melo, 1994). However, after the hybrid transcript has ... See full document

... The patient journey during their treatment of CML presents a similar emotional pattern as manifested in other types of cancer treatment. Macdonald et al. [31] suggest a five-stage treatment journey for metastatic ... See full document

... Chronic myeloid leukaemia (CML) is a kind of cancer that affects the white blood cells and resort to progress slowly through many ...as chronic myelocytic or chronic myelogenous ... See full document

... CML: chronic myeloid leukemia; CMML: chronic myelomonocytic leukaemia; CMP: common myeloid progenitor; CSF-1R: colony stimulating factor-1 (CSF-1) receptor; FLT3: fms-related tyrosine ... See full document

... The initial or chronic phase is insidious and typically characterised by vague feelings of ill health, weight loss, fever, or symptoms of anaemia. Pain associated with an enlargement of the spleen is the most ... See full document

... in chronic phase contain DST plasma levels 30-fold lower than the drug concentrations chosen for our experiments, we decided to use also 1 μM DST as we have previously shown that not all Gab2 amplified signalling ... See full document

... disease-free patients when describing the CML patient health status. Comparing the interpretation value of these two quantities to the overall survival (OS), both advantages and disadvantages can be seen. Obviously, the ... See full document

... BCR-ABL in this study showed a positive correlation with miRNA-150 at molecular remission level. This implies that once patients who are on imatinib achieve molecular remission of the chronic myeloid ... See full document

... in myeloid cells to cell cycle progression, cell motility and growth factor signalling in normal cells ...lymphoblastic leukaemia [12], myelodysplastic syndrome [13] and chronic and acute ... See full document

... Application of cDNA arrays is restricted because of its cost and its need to fairly large amounts of RNA in routine clinical practise. In order to surmount these obstacles, a global amplification approach, which is known ... See full document

... From a cohort of 10 CML patients enrolled in a clinical trial studying IM in chronic phase (Novartis studies 0106 and 0113), matched peripheral blood and bone marrow aspirate samples were processed to determine ... See full document

... The target strand used is an ODN model of the bcr/abl oncogenic mRNA present in chronic myeloid leukaemia (CML). As such, the aim of this research is the development of potential photoactive ... See full document

... We recently reported that chronic myeloid leukaemia (CML) patients harbour high levels of STAT5 when they progress to advanced phases of disease. Advanced disease is characterized by an increased ... See full document

... Imatinib mesilate (Glivec s , Novartis Pharmaceuticals) is a novel therapy for the treatment of chronic myeloid leukaemia (CML). We evaluated the cost-effectiveness of imatinib (600 mg daily) when ... See full document

... apoptosis in both cell lines, it induced a very large decrease in Mcl-1 levels, but only in the KCL-22 cell line. This effect was specific for Mcl-1 and was not observed for other anti-apoptotic proteins measured. This ... See full document

... myelogenous leukaemia (CML) is a clonal myeloproliferative disorder, characterized by presence of Philadelphia (Ph) chromosome [1]-[5], which is a reciprocal translocation t (9q34; 22q11) that creates an aber- ... See full document

... The Chronic myeloid leukaemia cell lines (K562) and normal cell lines (L02) were infected with Ad-wt, AdCN205-EGFP, AdCN205-IL-24, AdCN205-11- EGFP and AdCN205-11-IL-24 at a MOI of ...CML, ... See full document